Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.

[1]  D. Berkvens,et al.  Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field. , 2007, Vaccine.

[2]  S. Reid,et al.  Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. , 2007, Journal of virological methods.

[3]  M. Greiner,et al.  Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. , 2006, Vaccine.

[4]  D. Stuart,et al.  Specificity of the VP1 GH Loop of Foot-and-Mouth Disease Virus for αv Integrins , 2006, Journal of Virology.

[5]  S. Reid,et al.  Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. , 2005, Vaccine.

[6]  S. Reid,et al.  Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. , 2004, Vaccine.

[7]  P. Rottier,et al.  Generation of a Candidate Live Marker Vaccine for Equine Arteritis Virus by Deletion of the Major Virus Neutralization Domain , 2003, Journal of Virology.

[8]  P. Barnett,et al.  Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. , 2003, Vaccine.

[9]  B. Baxt,et al.  Foot-and-Mouth Disease Virus Receptors: Comparison of Bovine αV Integrin Utilization by Type A and O Viruses , 2003, Journal of Virology.

[10]  T. Mebatsion,et al.  Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Replaced by a Foreign Epitope , 2002, Journal of Virology.

[11]  K. McCullough,et al.  Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. , 2002, Vaccine.

[12]  Zhidong Zhang,et al.  Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. , 2002, Journal of virological methods.

[13]  P. V. van Rijn,et al.  Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. , 2002, Vaccine.

[14]  L. Babiuk,et al.  Novel vaccine strategies. , 2002, Advances in virus research.

[15]  G. Koch,et al.  Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. , 2001, Vaccine.

[16]  P. V. van Rijn,et al.  Classical Swine Fever Virus ErnsDeletion Mutants: trans-Complementation and Potential Use as Nontransmissible, Modified, Live-Attenuated Marker Vaccines , 2000, Journal of Virology.

[17]  J. Salt,et al.  Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. , 1998, Vaccine.

[18]  D. Mackay,et al.  Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. , 1998, The Veterinary quarterly.

[19]  K. Sorensen,et al.  Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus , 1998, Archives of Virology.

[20]  J. Stegeman,et al.  The use of marker vaccines in eradication of herpesviruses. , 1996, Journal of biotechnology.

[21]  P. Mason,et al.  Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV , 1994, Journal of virology.

[22]  P. Barnett,et al.  Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. , 1994, Vaccine.

[23]  R. Dölling,et al.  RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro. , 1991, Acta virologica.

[24]  V. Vakharia,et al.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus , 1989, Journal of virology.

[25]  H. Schaller,et al.  Analysis of neutralizing epitopes on foot-and-mouth disease virus , 1988, Journal of virology.

[26]  M. Dawson,et al.  Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. , 1988, Veterinary microbiology.

[27]  J. Mattick,et al.  Identification of major antigenic proteins of bovine herpesvirus 1 and their correlation with virus neutralizing activity. , 1988, Veterinary Microbiology.

[28]  M. Rweyemamu.  Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction. , 1984, Journal of biological standardization.

[29]  G. Schulz,et al.  Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. , 1982, The EMBO journal.

[30]  Richard A. Houghten,et al.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence , 1982, Nature.

[31]  D. Rowlands,et al.  Evidence for an internal antigen in foot-and-mouth disease virus. , 1969, The Journal of general virology.